Drug maker Pfizer has decided to discontinue the manufacturing of Corex cough syrup. New Delhi: Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ...

The agreement gives Cipla sole rights to sell and distribute the two Corex variants along with some other drugs Pfizer will continue to manufacture and supply the products ...

The court’s order came on a plea moved by Pfizer, which contended that no show-cause notice or hearing was granted prior to the notification. Photo: Reuters New Delhi: In a major relief to US ...

Pharmaceutical company Pfizer has with immediate effect stopped making and selling cough syrup Corex in India after the government prohibited fixed dose combination of Chlopheniramine Maleate + ...

REUTERS - Delhi High Court granted U.S. drugmaker Pfizer an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk ...

MUMBAI, March 14 (Reuters) - U.S. pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to ...

The Delhi High Court granted an interim stay of a notification restraining sale of pharma major Pfizer's cough syrup Corex, and directed the government not to take coercive steps against the company.

Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio. The company has also decided to ...

Pfizer Q4 results: The company's standalone total income from operations rose to Rs 515.1 crore for the quarter under review as against Rs 463.1 crore a year ago. In a relief to pharma major Pfizer ...